Cart
sales@molnova.com
BIX02189 (b)
CAS No. 1094614-85-3
BIX02189 (b)( —— )
Catalog No. M10368 CAS No. 1094614-85-3
BIX02189 is a selective inhibitor of MEK5 with IC50 of 1.5 nM, also inhibits ERK5 catalytic activity with IC50 of 59 nM in cell-free assays.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 43 | In Stock |
|
| 5MG | 71 | In Stock |
|
| 10MG | 113 | In Stock |
|
| 25MG | 210 | In Stock |
|
| 50MG | 357 | In Stock |
|
| 100MG | 615 | In Stock |
|
| 200MG | 857 | In Stock |
|
| 500MG | 1251 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBIX02189 (b)
-
NoteResearch use only, not for human use.
-
Brief DescriptionBIX02189 is a selective inhibitor of MEK5 with IC50 of 1.5 nM, also inhibits ERK5 catalytic activity with IC50 of 59 nM in cell-free assays.
-
DescriptionBIX02189 is a selective inhibitor of MEK5 with IC50 of 1.5 nM, also inhibits ERK5 catalytic activity with IC50 of 59 nM in cell-free assays, and does not inhibit closely related kinases MEK1, MEK2, ERK2, and JNK2.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMAPK/ERK Signaling
-
TargetERK
-
RecptorERK5| MEK1| MEK2| MEK5| TGFβR1
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1094614-85-3
-
Formula Weight440.54
-
Molecular FormulaC27H28N4O2
-
Purity>98% (HPLC)
-
SolubilityEthanol: 80 mg/mL (181.59 mM); DMSO: 60 mg/mL warmed (136.19 mM)
-
SMILESCN(C)CC1=CC(=CC=C1)N/C(=C\2/C3=C(C=C(C=C3)C(=O)N(C)C)NC2=O)/C4=CC=CC=C4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Tatake RJ, et al. Biochem Biophys Res Commun, 2008, 377(1), 120-125.
molnova catalog
related products
-
AZ6197
AZ6197 (AZ-6197) is a potent, selective, reversible inhibitor of ERK1/2 with IC50 of <0.3 nM (ERK2).
-
MK-8353
MK-8353 (SCH-900353) is a?highly potent, orally bioavailable, dual-specificity ERK1/2 inhibitor with IC50 of 23.0/8.8 nM, respectively.
-
ERK5-IN-5
ERK5-IN-5 is a potent extracellular signal-regulated kinase 5 (ERK5) inhibitor with anticancer activity and potential anticonvulsant activity that inhibits A549 cell proliferation.
